The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davidson, D. J.
Right arrow Articles by Speert, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davidson, D. J.
Right arrow Articles by Speert, D. P.
The Journal of Immunology, 2006, 177: 8202-8211.
Copyright © 2006 by The American Association of Immunologists, Inc.

IRAK-4 Mutation (Q293X): Rapid Detection and Characterization of Defective Post-Transcriptional TLR/IL-1R Responses in Human Myeloid and Non-Myeloid Cells1

Donald J. Davidson*,2,3, Andrew J. Currie*,2,4, Dawn M. E. Bowdish{dagger}, Kelly L. Brown{dagger}, Carrie M. Rosenberger*, Rebecca C. Ma*, Johan Bylund*, Paul A. Campsall*, Anne Puel{ddagger}, Capucine Picard{ddagger}, Jean-Laurent Casanova{ddagger}, Stuart E. Turvey*, Robert E. W. Hancock{dagger}, Rebecca S. Devon* and David P. Speert*

* Child and Family Research Institute and {dagger} Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada; and {ddagger} Laboratoire de Génétique Humaine des Maladies Infectieuses, Institut National de la Santé et de la Recherche Médicale Unité 550, Faculté de Médecine Necker-Enfants Malades, Paris, France

Innate immunodeficiency has recently been reported as resulting from the Q293X IRAK-4 mutation with consequent defective TLR/IL-1R signaling. In this study we report a method for the rapid allele-specific detection of this mutation and demonstrate both cell type specificity and ligand specificity in defective IL-1R-associated kinase (IRAK)-4-deficient cellular responses, indicating differential roles for this protein in human PBMCs and primary dermal fibroblasts and in LPS, IL-1beta, and TNF-{alpha} signaling. We demonstrate transcriptional and post-transcriptional defects despite NF-{kappa}B signaling and intact MyD88-independent signaling and propose that dysfunctional complex 1 (IRAK1/TRAF6/TAK1) signaling, as a consequence of IRAK-4 deficiency, generates specific defects in MAPK activation that could underpin this patient’s innate immunodeficiency. These studies demonstrate the importance of studying primary human cells bearing a clinically relevant mutation; they underscore the complexity of innate immune signaling and illuminate novel roles for IRAK-4 and the fundamental importance of accessory proinflammatory signaling to normal human innate immune responses and immunodeficiencies.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 D.J.D. and R.S.D. are funded by Wellcome Trust Grants 060168 and 060161, D.J.D., A.J.C., and J.B. were supported by the Canadian Cystic Fibrosis Foundation, D.M.E.B. is supported by a Canadian Institutes for Health Research (CIHR) studentship, K.L.B. holds a fellowship from the CIHR-University of British Columbia Strategic Training Program for Translational Research in Infectious Diseases, C.M.R. holds studentships from CIHR and the Michael Smith Foundation for Health Research, R.E.W.H. holds a Canada Research Chair and was supported by a Pathogenomics of Innate Immunity grant provided by Genome British Columbia, and D.P.S. is supported by operating grants from CIHR and the Canadian Bacterial Diseases Network.

2 D.J.D. and A.J.C. contributed equally to this study.

3 Address correspondence and reprint requests to Dr. Donald J. Davidson at the current address: Medical Research Council/University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute W2.05, 47 Little France Crescent, Edinburgh EH16 4TJ, Scotland. E-mail address: Donald.Davidson{at}ed.ac.uk

4 Current address: Department of Medicine, University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009.

5 Abbreviations used in this paper: IRAK, IL-1R-associated kinase; DD, death domain; hnRNA, heteronuclear RNA; IKK, I-{kappa}B kinase; MDDC, monocyte-derived dendritic cell; MDM, monocyte-derived macrophage; MKK, MAPK kinase; poly(I:C), polyinosinic acid/polycytidylic acid; TAK, TGF-beta-activated kinase; TRAF, TNFR-associated factor.




This article has been cited by other articles:


Home page
J BiochemHome page
M. Kubo-Murai, K. Hazeki, K. Nigorikawa, T. Omoto, N. Inoue, and O. Hazeki
IRAK-4-dependent Degradation of IRAK-1 is a Negative Feedback Signal for TLR-mediated NF-{kappa}B Activation
J. Biochem., March 1, 2008; 143(3): 295 - 302.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C.-L. Ku, H. von Bernuth, C. Picard, S.-Y. Zhang, H.-H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, et al.
Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity
J. Exp. Med., October 1, 2007; 204(10): 2407 - 2422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Hoarau, B. Gerard, E. Lescanne, D. Henry, S. Francois, J.-J. Lacapere, J. El Benna, P. M.-C. Dang, B. Grandchamp, Y. Lebranchu, et al.
TLR9 Activation Induces Normal Neutrophil Responses in a Child with IRAK-4 Deficiency: Involvement of the Direct PI3K Pathway
J. Immunol., October 1, 2007; 179(7): 4754 - 4765.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.